PPARγ, a critical factor in the regulation of hepatic lipogenesis, is also reported to be robustly induced in the livers of patients, as well as in preclinical models of NAFLD (Hasenfuss et al., 2014; Platko et al., 2019). Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.